Cyclo Therapeutics earnings were -$24.8M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest CYTH earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$8.8M, up 47.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, CYTH reported annual earnings of -$20.1M, with 29.8% growth. The next CYTH earnings date is Mar 17, 2025.
What were Cyclo Therapeutics's earnings last quarter?
On CYTH's earnings call on Invalid Date, Cyclo Therapeutics (NASDAQ: CYTH) reported Q3 2024 earnings per share (EPS) of -$0.31, up 6.9% year over year. Total CYTH earnings for the quarter were -$8.83 million. In the same quarter last year, Cyclo Therapeutics's earnings per share (EPS) was -$0.29.
The next CYTH earnings call is Invalid Date. Add CYTH to your watchlist to be reminded of Cyclo Therapeutics's next earnings date.
What was CYTH's earnings growth in the past year?
As of Cyclo Therapeutics's earnings date in Invalid Date, Cyclo Therapeutics's earnings has grown year over year. CYTH earnings in the past year totalled -$24.80 million.
Is Cyclo Therapeutics profitable or losing money?
As of the last Cyclo Therapeutics earnings report, Cyclo Therapeutics is currently losing money. Cyclo Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$24.80 million, a 27.86% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.